Association of Maternal ABO Blood Type with Lesion Level and Birthweight of Children with Spina Bifida: a Descriptive Study

Overview

Journal J Med Life

Specialty General Medicine

Date 2024 Aug 15

PMID 39144690

Authors

Thomas Lee Farley

Affiliations

Soon will be listed here.

Abstract

The etiology of spina bifida, a neural tube birth defect, is largely unknown, but a majority of cases are thought to be genetic in origin. Although maternal blood type was found not to be associated with the occurrence of spina bifida, the analysis was never extended to other aspects of the disorder. The purpose of this descriptive study was to determine if maternal blood type was related to characteristics of children with spina bifida. The blood type of 221 mothers of children with spina bifida enrolled on the Arkansas Spinal Cord Disability Registry from 1995 to 2008 was obtained by mailed questionnaire. All children were community-dwelling and from singleton pregnancies. As expected, analysis of mother-child data showed that the distribution of mothers' blood type was not statistically different from the general population (chi-squared, = 0.9203). However, the blood type of these mothers was associated with their child's lesion level (chi-squared, = 0.011). Mothers with blood type A more frequently had children with thoracic lesions; mothers with non-A blood types more frequently had children with lumbar and sacral lesions. In addition, mean birthweight differed by mothers' blood type (analysis of variance, = 0.025). Children of mothers with blood type A had the highest mean birthweight, while those of mothers with blood type AB had the lowest. Also, hydrocephalus was present more frequently in children with thoracic lesions compared to those with lumbar and sacral lesions (chi-squared, = 0.001). Interestingly, these results were significant for female children but not for male children. In conclusion, maternal blood type was associated with lesion level and birthweight of children with spina bifida.

References

Frey L, Hauser W . Epidemiology of neural tube defects. Epilepsia. 2003; 44 Suppl 3:4-13. DOI: 10.1046/j.1528-1157.44.s3.2.x. View

Kumar P, Kuhlmann F, Chakraborty S, Louis Bourgeois A, Foulke-Abel J, Tumala B . Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity. J Clin Invest. 2019; 129(7):2980. PMC: 6597215. DOI: 10.1172/JCI130874. View

Sherry C, Baker D . Spina bifida and maternal Rh phenotype. Experientia. 1982; 38(3):323-4. DOI: 10.1007/BF01949369. View

Kim I, Hopson B, Aban I, Rizk E, Dias M, Bowman R . Treated hydrocephalus in individuals with myelomeningocele in the National Spina Bifida Patient Registry. J Neurosurg Pediatr. 2018; 22(6):646-651. PMC: 8927992. DOI: 10.3171/2018.5.PEDS18161. View

Abegaz S . Human ABO Blood Groups and Their Associations with Different Diseases. Biomed Res Int. 2021; 2021:6629060. PMC: 7850852. DOI: 10.1155/2021/6629060. View

Hochstetler A, Raskin J, Blazer-Yost B . Hydrocephalus: historical analysis and considerations for treatment. Eur J Med Res. 2022; 27(1):168. PMC: 9434947. DOI: 10.1186/s40001-022-00798-6. View

Verhoef M, Barf H, Post M, van Asbeck F, Gooskens R, Prevo A . Secondary impairments in young adults with spina bifida. Dev Med Child Neurol. 2004; 46(6):420-7. DOI: 10.1017/s0012162204000684. View

Avagliano L, Massa V, George T, Qureshy S, Bulfamante G, Finnell R . Overview on neural tube defects: From development to physical characteristics. Birth Defects Res. 2018; 111(19):1455-1467. PMC: 6511489. DOI: 10.1002/bdr2.1380. View

Farley T . A reproductive history of mothers with spina bifida offspring--a new look at old issues. Cerebrospinal Fluid Res. 2006; 3:10. PMC: 1557536. DOI: 10.1186/1743-8454-3-10. View

10.

Martinez de Villarreal L, Arredondo P, Hernandez R, Villarreal J . Weekly administration of folic acid and epidemiology of neural tube defects. Matern Child Health J. 2006; 10(5):397-401. DOI: 10.1007/s10995-006-0082-2. View

11.

MacMahon B, PUGH T, Ingalls T . Anencephalus, spina bifida, and hydrocephalus incidence related to sex, race, and season of birth, and incidence in siblings. Br J Prev Soc Med. 1953; 7(4):211-9. PMC: 1058516. DOI: 10.1136/jech.7.4.211. View

12.

Bamforth S, Baird P . Spina bifida and hydrocephalus: a population study over a 35-year period. Am J Hum Genet. 1989; 44(2):225-32. PMC: 1715406. View

13.

Byrne J, Cama A, Reilly M, Vigliarolo M, Levato L, Boni L . Multigeneration maternal transmission in Italian families with neural tube defects. Am J Med Genet. 1996; 66(3):303-10. DOI: 10.1002/(SICI)1096-8628(19961218)66:3<303::AID-AJMG13>3.0.CO;2-Q. View

14.

Golding J, Butler N . Spina bifida and maternal Rh blood type. Arch Dis Child. 1980; 55(3):244. PMC: 1626756. DOI: 10.1136/adc.55.3.244. View

15.

Park C, Stewart W, Khoury M, Mulinare J . Is there etiologic heterogeneity between upper and lower neural tube defects?. Am J Epidemiol. 1992; 136(12):1493-501. DOI: 10.1093/oxfordjournals.aje.a116470. View

16.

Detrait E, George T, Etchevers H, Gilbert J, Vekemans M, Speer M . Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol Teratol. 2005; 27(3):515-24. PMC: 2727639. DOI: 10.1016/j.ntt.2004.12.007. View

17.

Wald N, Cuckle H, Boreham J, Althouse R . Birth weight of infants with spina bifida cystica. Br J Obstet Gynaecol. 1980; 87(7):578-81. DOI: 10.1111/j.1471-0528.1980.tb05007.x. View

18.

Copp A, Scott Adzick N, Chitty L, Fletcher J, Holmbeck G, Shaw G . Spina bifida. Nat Rev Dis Primers. 2016; 1:15007. PMC: 4898641. DOI: 10.1038/nrdp.2015.7. View

19.

Poletta F, Rittler M, Saleme C, Campana H, Gili J, Pawluk M . Neural tube defects: Sex ratio changes after fortification with folic acid. PLoS One. 2018; 13(3):e0193127. PMC: 5851584. DOI: 10.1371/journal.pone.0193127. View

20.

Mai C, Evans J, Alverson C, Yue X, Flood T, Arnold K . Changes in Spina Bifida Lesion Level after Folic Acid Fortification in the US. J Pediatr. 2022; 249:59-66.e1. PMC: 10250025. DOI: 10.1016/j.jpeds.2022.06.023. View